- Home
- ALXO vs TRX Comparison
ALXO vs TRX Comparison
Compare ALXO & TRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- TRX
- Stock Information
- Founded
- ALXO 2015
- TRX 1990
- Country
- ALXO United States
- TRX Canada
- Employees
- ALXO N/A
- TRX N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- TRX
- Sector
- ALXO Health Care
- TRX
- Exchange
- ALXO Nasdaq
- TRX Nasdaq
- Market Cap
- ALXO 76.5M
- TRX 81.1M
- IPO Year
- ALXO 2020
- TRX N/A
- Fundamental
- Price
- ALXO $0.55
- TRX $0.33
- Analyst Decision
- ALXO Strong Buy
- TRX Strong Buy
- Analyst Count
- ALXO 6
- TRX 2
- Target Price
- ALXO $4.14
- TRX $1.63
- AVG Volume (30 Days)
- ALXO 529.8K
- TRX 677.1K
- Earning Date
- ALXO 05-08-2025
- TRX 04-14-2025
- Dividend Yield
- ALXO N/A
- TRX N/A
- EPS Growth
- ALXO N/A
- TRX N/A
- EPS
- ALXO N/A
- TRX N/A
- Revenue
- ALXO N/A
- TRX $45,405,000.00
- Revenue This Year
- ALXO N/A
- TRX $68.64
- Revenue Next Year
- ALXO N/A
- TRX $22.37
- P/E Ratio
- ALXO N/A
- TRX N/A
- Revenue Growth
- ALXO N/A
- TRX 26.50
- 52 Week Low
- ALXO $0.46
- TRX $0.27
- 52 Week High
- ALXO $17.83
- TRX $0.49
- Technical
- Relative Strength Index (RSI)
- ALXO 37.26
- TRX 57.32
- Support Level
- ALXO $0.46
- TRX $0.31
- Resistance Level
- ALXO $0.63
- TRX $0.33
- Average True Range (ATR)
- ALXO 0.06
- TRX 0.02
- MACD
- ALXO 0.02
- TRX 0.01
- Stochastic Oscillator
- ALXO 42.86
- TRX 66.67
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About TRX TRX Gold Corporation
TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. Its projects include the Buckreef project, and Itetemia Gold project whereas, its exploration stage project consists of the Lunguya project and the Luhala project.